Literature DB >> 7619052

Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme.

Y Liang1, P Kesavan, L Q Wang, K Niswender, Y Tanizawa, M A Permutt, M A Magnuson, F M Matschinsky.   

Abstract

Mutations in the human glucokinase (GK) gene are thought to cause maturity-onset diabetes of youth (MODY) by leading to the production of enzymes with reduced catalytic activities and increased glucose Km values. However, in some cases the diabetic phenotype is more severe than might be predicted from these apparent kinetic effects alone. To determine whether these mutations might also effect other characteristics of the enzyme, nine MODY-associated mutants were expressed as fusion proteins with Schistosoma japonicum glutathione S-transferase (GST) and compared with three wild-type human GK isoforms that were also expressed in the same manner. Three GST-GK isoforms (liver 1, liver 2 and islet) were kinetically indistinguishable from each other and from purified rat liver GK. Noteworthy is a glucose-induced fit effect for the interaction of trinitrophenyl (TNP)-ATP with GST-GK, whereby glucose significantly increased the affinity of TNP-ATP binding to GST-GK without changing the stoichiometry of binding. The nine MODY-associated mutations studied either showed diminished catalytic activity, substrate affinities, allosteric regulation, or stability of the fusion enzyme. We conclude that: (1) Gly261 and Lys414 are important for ATP binding; (2) Val203 may be essential for a glucose-induced fit effect; and (3) the stability of fusion protein may be significantly reduced when Glu300 is replaced by Lys. These results suggest that, in addition to effects on the Km and Vmax. of GK, a decrease in the ATP-binding affinity or stability of the mutated enzyme may also contribute to a reduction of GK activity in individuals with GK-MODY. In the B-cell this would have the effect of blunting glucose-stimulated insulin release, thereby contributing to the diabetic phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619052      PMCID: PMC1135815          DOI: 10.1042/bj3090167

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

Review 2.  Regulation of glucokinase in liver.

Authors:  S Weinhouse
Journal:  Curr Top Cell Regul       Date:  1976

3.  Kinetics of rat liver glucokinase. Co-operative interactions with glucose at physiologically significant concentrations.

Authors:  A C Storer; A Cornish-Bowden
Journal:  Biochem J       Date:  1976-10-01       Impact factor: 3.857

4.  Metabolism of glucose in the islets of Langerhans.

Authors:  F M Matschinsky; J E Ellerman
Journal:  J Biol Chem       Date:  1968-05-25       Impact factor: 5.157

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Measurement of ligand binding to proteins by fluorescence spectroscopy.

Authors:  L D Ward
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

7.  A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors.

Authors:  A Cornish-Bowden
Journal:  Biochem J       Date:  1974-01       Impact factor: 3.857

8.  Crystallographic studies and model building of ATP at the active site of hexokinase.

Authors:  M Shoham; T A Steitz
Journal:  J Mol Biol       Date:  1980-06-15       Impact factor: 5.469

9.  Characterization of 2',3'-O-(2,4,6-trinitrocyclohexadienylidine)adenosine 5'-triphosphate as a fluorescent probe of the ATP site of sodium and potassium transport adenosine triphosphatase. Determination of nucleotide binding stoichiometry and ion-induced changes in affinity for ATP.

Authors:  E G Moczydlowski; P A Fortes
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

10.  Chromatographic resolution and kinetic characterization of glucokinase from islets of Langerhans.

Authors:  M D Meglasson; P T Burch; D K Berner; H Najafi; A P Vogin; F M Matschinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  31 in total

1.  Thermal stability of glucokinase (GK) as influenced by the substrate glucose, an allosteric glucokinase activator drug (GKA) and the osmolytes glycerol and urea.

Authors:  B Zelent; C Buettger; J Grimsby; R Sarabu; J M Vanderkooi; A J Wand; F M Matschinsky
Journal:  Biochim Biophys Acta       Date:  2012-03-16

2.  Structure-function analysis of the alpha5 and the alpha13 helices of human glucokinase: description of two novel activating mutations.

Authors:  Leda Pedelini; Maria Adelaida Garcia-Gimeno; Alberto Marina; Juan M Gomez-Zumaquero; Pablo Rodriguez-Bada; Soledad López-Enriquez; Federico C Soriguer; Antonio L Cuesta-Muñoz; Pascual Sanz
Journal:  Protein Sci       Date:  2005-06-29       Impact factor: 6.725

3.  Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).

Authors:  C V Burke; C W Buettger; E A Davis; S J McClane; F M Matschinsky; S E Raper
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

4.  GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation.

Authors:  Maria Negahdar; Ingvild Aukrust; Bente B Johansson; Janne Molnes; Anders Molven; Franz M Matschinsky; Oddmund Søvik; Rohit N Kulkarni; Torgeir Flatmark; Pål Rasmus Njølstad; Lise Bjørkhaug
Journal:  Biochim Biophys Acta       Date:  2012-07-20

5.  Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.

Authors:  María Galán; Olivier Vincent; Isabel Roncero; Sharona Azriel; Pedro Boix-Pallares; Elías Delgado-Alvarez; Francisco Díaz-Cadórniga; Enrique Blázquez; María-Angeles Navas
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 6.  Homotropic allosteric regulation in monomeric mammalian glucokinase.

Authors:  Mioara Larion; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2011-11-15       Impact factor: 4.013

7.  Tryptophan Fluorescence Yields and Lifetimes as a Probe of Conformational Changes in Human Glucokinase.

Authors:  Bogumil Zelent; Chris Bialas; Ignacy Gryczynski; Pan Chen; Rahul Chib; Karina Lewerissa; Maria G Corradini; Richard D Ludescher; Jane M Vanderkooi; Franz M Matschinsky
Journal:  J Fluoresc       Date:  2017-04-22       Impact factor: 2.217

8.  High-resolution electrospray ionization Fourier transform mass spectrometry with infrared multiphoton dissociation of glucokinase from Bacillus Stearothermophilus.

Authors:  C P Dufresne; T D Wood; C L Hendrickson
Journal:  J Am Soc Mass Spectrom       Date:  1998-11       Impact factor: 3.109

9.  Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.

Authors:  Shi-Ying Ding; Nicholas D Tribble; Catherine A Kraft; Michele Markwardt; Anna L Gloyn; Mark A Rizzo
Journal:  Mol Endocrinol       Date:  2009-11-24

10.  The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.

Authors:  Nicola L Beer; Nicholas D Tribble; Laura J McCulloch; Charlotta Roos; Paul R V Johnson; Marju Orho-Melander; Anna L Gloyn
Journal:  Hum Mol Genet       Date:  2009-07-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.